Patents by Inventor Takashi Hanafusa

Takashi Hanafusa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9138410
    Abstract: Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: September 22, 2015
    Assignee: Shin Nippon Biomedical Laboratories, Ltd.
    Inventors: Toshikazu Oki, Takashi Hanafusa, Shunji Haruta
  • Publication number: 20130287852
    Abstract: Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
    Type: Application
    Filed: March 14, 2013
    Publication date: October 31, 2013
    Inventors: Toshikazu OKI, Takashi HANAFUSA, Shunji HARUTA
  • Patent number: 8435554
    Abstract: Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
    Type: Grant
    Filed: December 30, 2008
    Date of Patent: May 7, 2013
    Assignee: Shin Nippon Biomedical Laboratories, Ltd.
    Inventors: Toshikazu Oki, Takashi Hanafusa, Shunji Haruta
  • Patent number: 7638138
    Abstract: Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: December 29, 2009
    Assignee: Translational Research, Ltd.
    Inventors: Toshikazu Oki, Takashi Hanafusa, Shunji Haruta
  • Publication number: 20090169640
    Abstract: Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
    Type: Application
    Filed: December 30, 2008
    Publication date: July 2, 2009
    Applicant: Translational Research, Ltd.
    Inventors: Toshikazu Oki, Takashi Hanafusa, Shunji Haruta
  • Publication number: 20060233715
    Abstract: Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
    Type: Application
    Filed: February 21, 2003
    Publication date: October 19, 2006
    Inventors: Toshikazu Oki, Takashi Hanafusa, Shunji Haruta
  • Publication number: 20050158250
    Abstract: Provided is an insulin-containing granulated composition for nasal administration comprising a crystalline cellulose aggregate having a specific particle diameter distribution as a carrier. Such granulated composition for nasal administration can efficiently increase a blood insulin concentration.
    Type: Application
    Filed: March 14, 2005
    Publication date: July 21, 2005
    Inventors: Toshikazu Oki, Takashi Hanafusa, Shunji Haruta
  • Patent number: 6906027
    Abstract: Provided is an insulin-containing granulated composition for nasal administration comprising a crystalline cellulose aggregate having a specific particle diameter distribution as a carrier. Such granulated composition for nasal administration can efficiently increase a blood insulin concentration.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: June 14, 2005
    Assignee: Translational Research Ltd.
    Inventors: Toshikazu Oki, Takashi Hanafusa, Shunji Haruta
  • Publication number: 20040063615
    Abstract: Provided is an insulin-containing granulated composition for nasal administration comprising a crystalline cellulose aggregate having a specific particle diameter distribution as a carrier. Such granulated composition for nasal administration can efficiently increase a blood insulin concentration.
    Type: Application
    Filed: July 9, 2003
    Publication date: April 1, 2004
    Inventors: Toshikazu Oki, Takashi Hanafusa, Shunji Haruta
  • Patent number: 4698332
    Abstract: An expectorant capable of acting on the rheological properties of sputum and capable of directly promoting the ciliary motion. The expectorant contains N-acetylneuraminic acid or a pharmaceutically active salt thereof.
    Type: Grant
    Filed: September 6, 1985
    Date of Patent: October 6, 1987
    Assignee: Mect Corporation
    Inventors: Sadanori Ogasawara, Takashi Hanafusa, Katsuhide Kariya, Masayoshi Ito, Yoshiyasu Shitori